Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite

This study has been terminated.
Sponsor:
Information provided by:
Brazilan Center for Studies in Dermatology
ClinicalTrials.gov Identifier:
NCT00399828
First received: November 14, 2006
Last updated: March 11, 2008
Last verified: March 2008
  Purpose

The purpose of this study is to assess the efficacy of device TRI-ACTIVETM (DEKA M.E.L.A., Itália)in the treatment od cellulite and body contouring.


Condition Intervention Phase
Cellulite
Body Contouring
Device: TRI-ACTIVE LASERDERMOLOGYTM (DEKA M.E.L.A., Itália)
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Clinical Study For Evaluation Of The Efficacy and Safety Of Tri-ActiveTM (Deka M.E.L.A., Itália) In Treatment Of Cellulite

Further study details as provided by Brazilan Center for Studies in Dermatology:

Primary Outcome Measures:
  • Assessment of effectiveness of treatment based on current classification of cellulite and evaluation corporal measures

Secondary Outcome Measures:
  • Assessment of subject's satisfaction
  • Visual assessments of the treated area before and after treatment
  • Safety analysis

Estimated Enrollment: 20
Study Start Date: August 2006
Estimated Study Completion Date: November 2006
Detailed Description:

The present study is a clinical, opened trial and single-center.

The patients will be treated by six laser diodes, localised cooling system and rhythmical intake massage device. Application of the massage will be performed for 8 weeks in a total of 16 treatment sessions: twice a week.

A set of photographs will be taken at visit 1 (baseline), visit 2 and 3 with standardized positions and lighting conditions.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Written Informed Consent;
  2. Subjects agreeing to take part of all procedures of the study (including mechanical massage, photographs), after being fully informed on the objectives and nature of the investigations;
  3. Female subjects between 18-45 years;
  4. Subjects presenting with cellulite grades I-III on buttocks and thighs;
  5. Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the device under investigation;
  6. Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollement untill the end of the study);
  7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0;
  8. Availability of the subject throughout the duration of the study (60 days);
  9. Availability of the subject in maintaining a stable weight during the study (variation less than 2 kg)
  10. Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.

Exclusion Criteria:

  1. Pregnant women or women intending to become pregnant during the study (next 3 months);
  2. BMI superior 25,0;
  3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis;
  4. Subjects participating in other clinical trials;
  5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled hypertension;
  6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises;
  7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be treated;
  8. Any prior aesthetic surgery affecting the area to be treated (liposuction, Subcision®), 3 months before the study, that may interfere with results;
  9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study;
  10. Subjects with inflammation or active infection in the area to be treated.
  11. Subjects with a history of adverse effects, which in the investigator's opinion should prevent the patient from participating in the study;
  12. Patients with cutaneous or vascular alterations, that difficult visualization and documentation of cellulite;
  13. Subjects with a history of medical treatment non-adherence or showing unwillingness to adhere to the study protocol;
  14. Subjects who can not come to the visits (one missing visit/ month is allowed);
  15. Subjects intending to initiate any intensive sport;
  16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics, corticosteroids, or diuretics;
  17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or self-tanning during the study;
  18. Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00399828

Sponsors and Collaborators
Brazilan Center for Studies in Dermatology
Investigators
Study Director: Doris Hexsel Brazilian Center fpr Dermatological Studies
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00399828     History of Changes
Other Study ID Numbers: 02CBED0602
Study First Received: November 14, 2006
Last Updated: March 11, 2008
Health Authority: Brazil: National Committee of Ethics in Research

ClinicalTrials.gov processed this record on September 18, 2014